These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26148707)

  • 1. The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform.
    Johnson A; Zeng J; Bailey AM; Holla V; Litzenburger B; Lara-Guerra H; Mills GB; Mendelsohn J; Shaw KR; Meric-Bernstam F
    Drug Discov Today; 2015 Dec; 20(12):1433-8. PubMed ID: 26148707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized cancer therapy-leveraging a knowledge base for clinical decision-making.
    Dumbrava EI; Meric-Bernstam F
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29212833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioneering the implementation of a precision oncology strategy in Portugal: the Precision Oncology Platform trial.
    Mainoli B; Assis J; Dinis J; Henrique R; Oliveira J
    Acta Oncol; 2024 Jun; 63():482-486. PubMed ID: 38910310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitions and statistical properties of master protocols for personalized medicine in oncology.
    Renfro LA; Mandrekar SJ
    J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Tumor Boards in Clinical Practice.
    Luchini C; Lawlor RT; Milella M; Scarpa A
    Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
    Arnall JR; Petro R; Patel JN; Kennedy L
    J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-of-1 Trials in Cancer Drug Development.
    Gouda MA; Buschhorn L; Schneeweiss A; Wahida A; Subbiah V
    Cancer Discov; 2023 Jun; 13(6):1301-1309. PubMed ID: 37070849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
    Molloy MP; Engel A
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
    [No Abstract]   [Full Text] [Related]  

  • 12. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trials and therapeutic intent in the age of precision oncology: What is a patient's chance of response?
    Tao DL; Kartika T; Tran A; Prasad V
    Eur J Cancer; 2020 Nov; 139():20-26. PubMed ID: 32957010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician interpretation of genomic test results and treatment selection.
    Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
    Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps.
    Printz C
    Cancer; 2020 Jan; 126(2):239-240. PubMed ID: 31917472
    [No Abstract]   [Full Text] [Related]  

  • 17. Community-driven development of a modified progression-free survival ratio for precision oncology.
    Mock A; Heilig CE; Kreutzfeldt S; Huebschmann D; Heining C; Schröck E; Brors B; Stenzinger A; Jäger D; Schlenk R; Glimm H; Fröhling S; Horak P;
    ESMO Open; 2019; 4(6):e000583. PubMed ID: 31798980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Workflow-driven clinical decision support for personalized oncology.
    Bucur A; van Leeuwen J; Christodoulou N; Sigdel K; Argyri K; Koumakis L; Graf N; Stamatakos G
    BMC Med Inform Decis Mak; 2016 Jul; 16 Suppl 2(Suppl 2):87. PubMed ID: 27460182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-centric trials for therapeutic development in precision oncology.
    Biankin AV; Piantadosi S; Hollingsworth SJ
    Nature; 2015 Oct; 526(7573):361-70. PubMed ID: 26469047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.